Cancer clinical trials in the region Pays de la Loire

199 currently recruiting clinical trials
Region Pays de la Loire

Phase 2 Lung cancer
#NCT05853575
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C Immunotherapy Chemotherapy
Targeted therapy Systemic Treatment-Naive Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Universitaire Angers (Angers )
Mirati Thérapeutique Inc.
Phase 2 Prostate cancer
#NCT05826509
Adenocarcinoma Localized Systemic Treatment-Naive Systemic Treatment-Naive None
6 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Régional Universitaire de Tours (Tours)
Institut Claudius Regaud
Phase 2 Liver and bile duct cancer
#NCT05797870
Hepatocellular carcinoma Localized None 1 2 Unhealthy A B C
6 main criterias to confirm
Centre Eugene Marquis (Rennes)
Centre Eugène Marquis
Phase 2 Colon cancer Rectal cancer
#NCT05706129
Locally Advanced Metastatic Chemotherapy Targeted therapy 1 2 3 or more
4 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2 Pancreas cancer
#NCT05706129
Adenocarcinoma Locally Advanced Metastatic Chemotherapy 1 2 3 or more
5 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2 Kidney cancer
#NCT05706129
Clear cell carcinoma Locally Advanced Metastatic Targeted therapy Immunotherapy Targeted therapy 2 3 or more
6 main criterias to confirm
Centre Hospitalier Universitaire de Nantes (Nantes)
Debiopharm International SA
Phase 2 Lung cancer
#NCT05673187
NSCLC (Non-Small Cell Lung Cancer) Metastatic KRAS G12C Immunotherapy Chemotherapy 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
7 main criterias to confirm
Centre Hospitalier du Mans (Le Mans)
Thérapeutique Mirati Inc
Phase 2 Breast cancer
#NCT05625087
HER2 Negative HR Positive Metastatic PIK3CA Hormone therapy Systemic Treatment-Naive 1
8 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), Centre Eugene Marquis (Rennes), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon), Centre Hospitalier de Blois (Blois)
UNICANCER
Phase 2 Lung cancer
#NCT05617963
SCLC (Small Cell Lung Cancer) Localized Locally Advanced Systemic Treatment-Naive Systemic Treatment-Naive None
6 main criterias to confirm
Centre Hospitalier de Cholet (Cholet), Hôpital Privé du Confluent - Vivalto Santé (Nantes), Centre Hospitalier Universitaire Angers (Angers )
UNICANCER
Phase 2 Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic KRAS G12C Immunotherapy Chemotherapy PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) None
Targeted therapy Targeted therapy
10 main criterias to confirm
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
Mirati Thérapeutique Inc.